Arterial density increases as fibrosis advances, affecting disease outcomes. Tissue hypoxia and angiogenic factors like VEGF and transforming growth factor-β further drive disease progression, ...

Pulmonary fibrosis can develop following a lung injury, including COVID-19, but most cases arise without any clear cause. Once diagnosed, the disease rapidly damages the lung, and patients usually ...

Background: Combined pulmonary fibrosis and emphysema (CPFE ... Findings: Among the 976 RA patients, 414 (42.4%) developed interstitial lung disease (ILD), with 74 (7.6%) experiencing CPFE. In ...

Chronic obstructive pulmonary disease (COPD) is a group of progressive lung diseases that obstruct airflow. You may experience breathing difficulties, but you can treat and even prevent flare-ups.

Sionna Therapeutics is eyeing a $156 million IPO as the cystic-fibrosis-focused biotech looks to take its lead candidate into phase 2. The Waltham, Massachusetts-based company already unveiled ...

Chronic obstructive pulmonary disease (COPD) is a manifestation of structural violence ... 1 In COPD, this process can be described across five domains: avoidable lung harms, diagnostic delay, ...

“PF Basics: Info for Newly Diagnosed Patients” was created by the Pulmonary Fibrosis Foundation. The resource contains six modules on various topics pertaining to the disease. Receiving a ...

Background: Data examining the role of pulmonary rehabilitation (PR) in interstitial lung disease (ILD) are limited. We tested the hypothesis that PR can improve functional status and dyspnea in a ...

In 2022, more than 941,600 Americans died from cardiovascular disease. Heart disease remains the leading cause of death in the United States, according to a new report. The American Heart ...